Regeneron Pharmaceuticals Basic Forecasting Models to cross-verify your projections.We analyze noise-free headlines and recent hype associated with Regeneron Pharmaceuticals which may create opportunities for some arbitrage if properly timed. With Regeneron Pharmaceuticals hype-based prediction module you can estimate the value of Regeneron Pharmaceuticals from the prospective of Regeneron Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on Regeneron Pharmaceuticals over a specific investment horizon. Additionally take a look at
|Horizon||30 Days Login to change|
Regeneron Pharmaceuticals After-Hype Price Density Analysis
Next price density
Regeneron Pharmaceuticals Estimiated After-Hype Price Volatility
September 18, 2019
Regeneron Pharmaceuticals is very steady asset. Analysis and calculation of next after-hype price of Regeneron Pharmaceuticals is based on 3 months time horizon.
Regeneron Pharmaceuticals Next Price Analysis
|Daily Expected return||Period Volatility||Hype elasticity||Related hype elasticity||Average news density||Related news density||Next Expected Hype|
|0.17%||1.80%||0.69%||0.06%||6 Events / Month||3 Events / Month||In about 6 days|
|Latest traded price||Expected after-news price||Potential return on next major news||Average after-hype volatility|
Regeneron Pharmaceuticals Hype TimelineRegeneron Pharmaceuticals is at this time traded for285.06. The entity has historical hype elasticity of -0.69 and average elasticity to hype of competition of -0.06. Regeneron Pharmaceuticals is projected to decline in value after the next headline with price expected to drop to 284.37. The average volatility of media hype impact on the company stock price is about 44.12%. The price decrease on the next news is expected to be -0.24% where as daily expected return is at this time at -0.17%. The volatility of related hype on Regeneron Pharmaceuticals is about 485.18% with expected price after next announcement by competition of 285.0. About 25.0% of the company outstanding shares are owned by corporate insiders. The book value of Regeneron Pharmaceuticals was at this time reported as 89.25. The company has Price/Earnings To Growth (PEG) ratio of 1.95. Regeneron Pharmaceuticals recorded earning per share (EPS) of 18.0. The entity had not issued any dividends in recent years. Given the investment horizon of 30 days, the next projected press release will be in about 6 days. Additionally take a look at Regeneron Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
Regeneron Pharmaceuticals Related Hype Analysis
|Vertex Pharmaceuticals Incorpor||(0.32)||8 per month||1.51||(0.0118)||2.39||(2.22)||11.20|
|Dr Reddys Laboratories Ltd||0.29||8 per month||1.34||0.0432||2.36||(2.49)||6.44|
|Sinovac Biotech Ltd||0.00||0 per month||0.00||0.00||0.00||0.00||0.00|
|Zoetis||1.02||8 per month||1.19||0.09||2.32||(2.33)||10.51|
|Immune Pharmaceuticals||0.00||0 per month||0.00||0.00||0.00||0.00||0.00|
|Perrigo Company plc||(0.59)||6 per month||1.79||0.17||3.33||(2.63)||9.83|
|PAREXEL International Corp||0.00||0 per month||0.00||0.00||0.00||0.00||0.00|
|Regeneron Pharmaceuticals||(4.08)||6 per month||0.00||(0.09)||2.53||(3.26)||8.75|
|SciClone Pharmaceuticals, In||0.00||0 per month||0.00||0.00||0.00||0.00||0.00|
|Origin Agritech Limited||(0.03)||3 per month||2.70||0.11||4.60||(3.77)||12.91|
Additionally take a look at Regeneron Pharmaceuticals Basic Forecasting Models to cross-verify your projections. Please also try Headlines Timeline module to stay connected to all market stories and filter out noise. drill down to analyze hype elasticity.